Role of lipids in Coxiella burnetii infection

Advances in Experimental Medicine and Biology

Volumn 984, Issue , 2012, Pages 199-213

  Gilk, Stacey D ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Cholesterol biosynthesis; Fatty acid synthesis; Membrane composition; Membrane fluidity; Phospholipid synthesis; Statin; Sterol reductase; Type IV secretion system

Indexed keywords

BACTERIAL ENZYME; CHOLESTEROL; FATTY ACID; FATTY ACID DERIVATIVE; ISOPRENOID; LIPID; PHOSPHOLIPASE A1; PHOSPHOLIPASE D; PHOSPHOLIPID; STEROL DERIVATIVE;

ARTICLE; BACTERIAL GENOME; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; BIOGENESIS; CELL MANIPULATION; CELL PH; CELL VACUOLE; CHOLESTEROL SYNTHESIS; ENERGY METABOLISM; ENZYME MODIFICATION; EUKARYOTE; FATTY ACID SYNTHESIS; HOST CELL; HOST PATHOGEN INTERACTION; INTRACELLULAR SIGNALING; LIPID COMPOSITION; LIPOGENESIS; LIPOLYSIS; MEMBRANE FLUIDITY; NONHUMAN; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; Q FEVER; TYPE IV SECRETION SYSTEM;

ANIMALS; COXIELLA BURNETII; HOST-PARASITE INTERACTIONS; HUMANS; LIPID METABOLISM; PHAGOSOMES; Q FEVER; SIGNAL TRANSDUCTION; VACUOLES;

BACTERIA (MICROORGANISMS); COXIELLA BURNETII; EUKARYOTA; PROKARYOTA;

EID: 84863763702     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-007-4315-1_10     Document Type: Article

References (63)

1. Amano K, Williams JC (1984) Chemical and immunological characterization of lipopolysaccharides from phase I and phase II Coxiella burnetii . J Bacteriol 160:994-1002
2. Amano K, Williams JC, Mccaul TF, Peacock MG (1984) Biochemical and immunological properties of Coxiella burnetii cell wall and peptidoglycan- protein complex fractions. J Bacteriol 160:982-988
3. Baca OG, Paretsky D (1983) Q fever and Coxiella burnetii: A model for host-parasite interactions. Microbiol Rev 47:127-149
4. Banerji S, Aurass P, Flieger A (2008) The manifold phospholipases A of Legionella pneumophila - identi fication, export, regulation, and their link to bacterial virulence. Int J Med Microbiol 298:169-181
5. Beare PA, Unsworth N, Andoh M, Voth DE, Omsland A, Gilk SD, Williams KP, Sobral BW, Kupko JJ 3rd, Porcella SF, Samuel JE, Heinzen RA (2009) Comparative genomics reveal extensive transposon-mediated genomic plasticity and diversity among potential effector proteins within the genus Coxiella . Infect Immun 77:642-656
6. Bergler H, Fuchsbichler S, Hogenauer G, Turnowsky F (1996) The enoyl-[acyl-carrier-protein] reductase (FabI) of Escherichia coli , which catalyzes a key regulatory step in fatty acid biosynthesis, accepts NADH and NADPH as cofactors and is inhibited by palmitoyl-CoA. Eur J Biochem 242:689-694
7. Bogdanov M, Heacock P, Guan Z, Dowhan W (2010) Plasticity of lipid-protein interactions in the function and topogenesis of the membrane protein lactose permease from Escherichia coli . Proc Natl Acad Sci U S A 107:15057-15062
8. Brombacher E, Urwyler S, Ragaz C, Weber SS, Kami K, Overduin M, Hilbi H (2009) Rab1 guanine nucleotide exchange factor SidM is a major phosphatidylinositol 4-phosphate-binding effector protein of Legionella pneumophila . J Biol Chem 284:4846-4856
9. Card GL, Trautman JK (1990) Role of anionic lipid in bacterial membranes. Biochim Biophys Acta 1047:77-82
10. Catron DM, Lange Y, Borensztajn J, Sylvester MD, Jones BD, Haldar K (2004) Salmonella enterica serovar Typhimurium requires nonsterol precursors of the cholesterol biosynthetic pathway for intracellular proliferation. Infect Immun 72:1036-1042
11. Chalmers JD, Singanayagam A, Murray MP, Hill AT (2008) Prior statin use is associated with improved outcomes in community-acquired pneumonia. Am J Med 121(1002-1007):e1
12. Chan ML, Mcchesney J, Paretsky D (1976) Further characterization of a lipopolysaccharide from Coxiella burneti . Infect Immun 13:1721-1727
13. Chow OA, Von Kockritz-Blickwede M, Bright AT, Hensler ME, Zinkernagel AS, Cogen AL, Gallo RL, Monestier M, Wang Y, Glass CK, Nizet V (2010) Statins enhance formation of phagocyte extracellular traps. Cell Host Microbe 8:445-454
14. Clejan S, Krulwich TA, Mondrus KR, Seto-Young D (1986) Membrane lipid composition of obligately and facultatively alkalophilic strains of Bacillus spp . J Bacteriol 168:334-340
15. Corvera E, Mouritsen OG, Singer ma, Zuckermann MJ (1992) The permeability and the effect of acyl-chain length for phospholipid bilayers containing cholesterol: theory and experiment. Biochim Biophys Acta 1107:261-270
16. Cossart P, Roy CR (2010) manipulation of host membrane machinery by bacterial pathogens. Curr Opin Cell Biol 22:547-554
17. Domingues P, Palkovic P, Toman R (2002) Analysis of phospholipids from Coxiella burnetii by fast atom bombardment mass spectrometry. A rapid method for differentiation of virulent phase I and low virulent phase II cells. Acta Virol 46:121-124
18. Gilk SD, Beare PA, Heinzen RA (2010) Coxiella burnetii expresses a functional {Delta}24 sterol reductase. J Bacteriol 192:6154-6159
19. Giotis ES, Mcdowell DA, Blair IS, Wilkinson BJ (2007) Role of branched-chain fatty acids in pH stress tolerance in Listeria monocytogenes . Appl Environ Microbiol 73:997-1001
20. Heath RJ, Su N, Murphy CK, Rock CO (2000) The enoyl-[acyl-carrier- protein] reductases FabI and FabL from Bacillus subtilis . J Biol Chem 275:40128-40133
21. Heinzen RA, Hackstadt T (1997) The Chlamydia trachomatis parasitophorous vacuolar membrane is not passively permeable to low-molecular-weight compounds. Infect Immun 65:1088-1094
22. Howe D, Heinzen RA (2006) Coxiella burnetii inhabits a cholesterol-rich vacuole and in fluences cellular cholesterol metabolism. Cell Microbiol 8:496-507
23. Jackson M, Stadthagen G, Gicquel B (2007) Long-chain multiple methyl-branched fatty acid-containing lipids of Mycobacterium tuberculosis: biosynthesis, transport, regulation and biological activities. Tuberculosis (Edinb) 87:78-86
24. Kaneda T (1991) Iso - and anteiso -fatty acids in bacteria: biosynthesis, function, and taxonomic signi ficance. Microbiol Rev 55:288-302
25. La Scola B, Raoult D (2001) Survival of Coxiella burnetii within free-living amoeba Acanthamoeba castellanii . Clin Microbiol Infect 7:75-79
26. Lange Y, Swaisgood MH, Ramos BV, Steck TL (1989) Plasma membranes contain half the phospholipid and 90% of the cholesterol and sphingomyelin in cultured human fibroblasts. J Biol Chem 264:3786-3793
27. Lange Y, Ye J, Chin J (1997) The fate of cholesterol exiting lysosomes. J Biol Chem 272:17018-17022
28. Liappis AP, Kan VL, Rochester CG, Simon GL (2001) The effect of statins on mortality in patients with bacteremia. Clin Infect Dis 33:1352-1357
29. Liscum L, Faust JR (1989) The intracellular transport of low density lipoprotein-derived cholesterol is inhibited in Chinese hamster ovary cells cultured with 3-beta-[2-(diethylamino)ethoxy] androst-5-en-17-one. J Biol Chem 264:11796-11806
30. Lu X, Kambe F, Cao X, Yoshida T, Ohmori S, Murakami K, Kaji T, Ishii T, Zadworny D, Seo H (2006) DHCR24-knockout embryonic fibroblasts are susceptible to serum withdrawal-induced apoptosis because of dysfunction of caveolae and insulin-Akt-Bad signaling. Endocrinology 147:3123-3132
31. Lu X, Kambe F, Cao X, Kozaki Y, Kaji T, Ishii T, Seo H (2008) 3beta-Hydroxysteroid-delta24 reductase is a hydrogen peroxide scavenger, protecting cells from oxidative stress-induced apoptosis. Endocrinology 149:3267-3273
32. Luhrmann A, Nogueira CV, Carey KL, Roy CR (2010) Inhibition of pathogen-induced apoptosis by a Coxiella burnetii type IV effector protein. Proc Natl Acad Sci U S A 107:18997-19001
33. massengo-Tiasse RP, Cronan JE (2008) Vibrio cholerae FabV de fines a new class of enoyl-acyl carrier protein reductase. J Biol Chem 283:1308-1316
34. massengo-Tiasse RP, Cronan JE (2009) Diversity in enoyl-acyl carrier protein reductases. Cell Mol Life Sci 66:1507-1517
35. Mccaul TF, Williams JC (1981) Developmental cycle of Coxiella burnetii: structure and morphogenesis of vegetative and sporogenic differentiations. J Bacteriol 147:1063-1076
36. Miyazaki C, Kuroda M, Ohta A, Shibuya I (1985) Genetic manipulation of membrane phospholipid composition in Escherichia coli: pgsA mutants defective in phosphatidylglycerol synthesis. Proc Natl Acad Sci U S A 82:7530-7534
37. Moliner C, Raoult D, Fournier PE (2009) Evidence that the intra-amoebal Legionella drancourtii acquired a sterol reductase gene from eukaryotes. BMC Res Notes 2:51
38. Needham D, Mcintosh TJ, Evans E (1988) Thermomechanical and transition properties of dimyristoylphosphatidylcholine/cholesterol bilayers. Biochemistry 27:4668-4673
39. Omsland A, Cockrell DC, Howe D, Fischer ER, Virtaneva K, Sturdevant DE, Porcella SF, Heinzen RA (2009) Host cell-free growth of the Q fever bacterium Coxiella burnetii . Proc Natl Acad Sci U S A 106:4430-4434
40. Ragaz C, Pietsch H, Urwyler S, Tiaden A, Weber SS, Hilbi H (2008) The Legionella pneumophila phosphatidylinositol-4 phosphate-binding type IV substrate SidC recruits endoplasmic reticulum vesicles to a replication- permissive vacuole. Cell Microbiol 10:2416-2433
41. Rodriguez-Acebes S, De La Cueva P, Ferruelo AJ, Fernandez-Hernando C, Lasuncion ma, martinez-Botas J, Gomez-Coronado D (2008) Dose-dependent dual effects of cholesterol and desmosterol on J774 macrophage proliferation. Biochem Biophys Res Commun 377:484-488
42. Rodriguez-Acebes S, De La Cueva P, Fernandez-Hernando C, Ferruelo AJ, Lasuncion ma, Rawson RB, martinez-Botas J, Gomez-Coronado D (2009) Desmosterol can replace cholesterol in sustaining cell proliferation and regulating the SREBP pathway in a sterol-Delta24- reductase-de ficient cell line. Biochem J 420:305-315
43. Rog T, Vattulainen I, Jansen M, Ikonen E, Karttunen M (2008) Comparison of cholesterol and its direct precursors along the biosynthetic pathway: effects of cholesterol, desmosterol and 7-dehydrocholesterol on saturated and unsaturated lipid bilayers. J Chem Phys 129:154508
44. Rosch JW, Boyd AR, Hinojosa E, Pestina T, Hu Y, Persons DA, Orihuela CJ, Tuomanen EI (2010) Statins protect against fulminant pneumococcal infection and cytolysin toxicity in a mouse model of sickle cell disease. J Clin Invest 120:627-635
45. Seshadri R, Paulsen IT, Eisen JA, Read TD, Nelson KE, Nelson WC, Ward NL, Tettelin H, Davidsen TM, Beanan MJ, Deboy RT, Daugherty SC, Brinkac LM, madupu R, Dodson RJ, Khouri HM, Lee KH, Carty HA, Scanlan D, Heinzen RA, Thompson HA, Samuel JE, Fraser CM, Heidelberg JF (2003) Complete genome sequence of the Q-fever pathogen Coxiella burnetii . Proc Natl Acad Sci U S A 100:5455-5460
46. Sexton RC, Panini SR, Azran F, Rudney H (1983) Effects of 3 beta-[2-(diethylamino)ethoxy] androst-5-en-17-one on the synthesis of cholesterol and ubiquinone in rat intestinal epithelial cell cultures. Biochemistry 22:5687-5692
47. Shibuya I, Miyazaki C, Ohta A (1985) Alteration of phospholipid composition by combined defects in phosphatidylserine and cardiolipin synthases and physiological consequences in Escherichia coli . J Bacteriol 161:1086-1092
48. Singh P, Saxena R, Paila YD, Jafurulla M, Chattopadhyay A (2009) Differential effects of cholesterol and desmosterol on the ligand binding function of the hippocampal serotonin(1A) receptor: implications in desmosterolosis. Biochim Biophys Acta 1788:2169-2173
49. Thomsen RW, Riis A, Kornum JB, Christensen S, Johnsen SP, Sorensen HT (2008) Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients. Arch Intern Med 168:2081-2087
50. Tsui MM, York JD (2010) Roles of inositol phosphates and inositol pyrophosphates in development, cell signaling and nuclear processes. Adv Enzyme Regul 50:324-337
51. Tzianabos T, Moss CW, Mcdade JE (1981) Fatty acid composition of rickettsiae. J Clin Microbiol 13:603-605
52. Vainio S, Jansen M, Koivusalo M, Rog T, Karttunen M, Vattulainen I, Ikonen E (2006) Signi ficance of sterol structural speci ficity. Desmosterol cannot replace cholesterol in lipid rafts. J Biol Chem 281:348-355
53. Voth DE, Heinzen RA (2009) Coxiella type IV secretion and cellular microbiology. Curr Opin Microbiol 12:74-80
54. Weber SS, Ragaz C, Reus K, Nyfeler Y, Hilbi H (2006) Legionella pneumophila exploits PI(4)P to anchor secreted effector proteins to the replicative vacuole. PLoS Pathog 2:e46
55. Weber SS, Ragaz C, Hilbi H (2009) Pathogen traf ficking pathways and host phosphoinositide metabolism. Mol Microbiol 71:1341-1352
56. Wechsler A, Brafman A, Sha fir M, Heverin M, Gottlieb H, Damari G, Gozlan-Kelner S, Spivak I, Moshkin O, Fridman E, Becker Y, Skaliter R, Einat P, Faerman A, Bjorkhem I, Feinstein E (2003) Generation of viable cholesterol-free mice. Science 302:2087
57. Wollenweber HW, Schramek S, Moll H, Rietschel ET (1985) Nature and linkage type of fatty acids present in lipopolysaccharides of phase I and II Coxiella burnetii . Arch Microbiol 142:6-11
58. Wu C, Miloslavskaya I, Demontis S, maestro R, Galaktionov K (2004) Regulation of cellular response to oncogenic and oxidative stress by Seladin-1. Nature 432:640-645
59. Wymann MP, Schneiter R (2008) Lipid signalling in disease. Nat Rev Mol Cell Biol 9:162-176
60. Xiong Q, Lin M, Rikihisa Y (2009) Cholesterol-dependent Anaplasma phagocytophilum exploits the low-density lipoprotein uptake pathway. PLoS Pathog 5:e1000329
61. Zhang YM, Rock CO (2008) Membrane lipid homeostasis in bacteria. Nat Rev Microbiol 6:222-233
62. Zhang W, Campbell HA, King SC, Dowhan W (2005) Phospholipids as determinants of membrane protein topology. Phosphatidylethanolamine is required for the proper topological organization of the gamma-aminobutyric acid permease (GabP) of Escherichia coli . J Biol Chem 280:26032-26038
63. Zweytick D, Hrastnik C, Kohlwein SD, Daum G (2000) Biochemical characterization and subcellular localization of the sterol C-24(28) reductase, Erg4p, from the yeast Saccharomyces cerevisiae . FEBS Lett 470:83-87